Study Confirms Dinutuximab Extends Life for Children with High-Risk NeuroblastomaPosted:
Researchers have confirmed that the immunotherapy drug dinutuximab (Unituxin) can help children with high-risk neuroblastoma live longer. The finding is based on a trial of nearly 1,200 children with the disease.
For Children with Neuroblastoma, Trial Results Highlight Continued Evolution of TreatmentPosted:
For many children with high-risk neuroblastoma, receiving two separate stem cell transplants is more beneficial than receiving one, according to the results of an NCI-supported clinical trial conducted by the Children’s Oncology Group.
New Drug for Pediatric Neuroblastoma Shows Promise in Preclinical StudiesPosted:
An international research team has identified a possible new treatment target for pediatric neuroblastoma and is planning an early-stage clinical trial of a drug that inhibits this target.